首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1402415

血漿衍生治療市場- 副產品（免疫球蛋白、凝血因子、白蛋白）、應用（血友病、原發性免疫缺陷病、特發性/免疫性血小板減少性紫斑症(ITP)）、全球預測，2023 -2032 年

Plasma Derived Therapy Market - By Product (Immunoglobulins, Coagulation Factors, Albumin), Application (Hemophilia, Primary Immunodeficiency Diseases, Idiopathic/Immune Thrombocytopenic Purpura (ITP)), Global Forecast, 2023-2032

出版日期: 2023年11月28日 | 出版商:

Global Market Insights Inc. | 英文 90 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

由於血漿採集中心和製造設施網路不斷擴大，2023 年至 2032 年間，全球血漿衍生治療市場將以 7.5% 的CAGR成長。這些基礎設施的不斷成長滿足了對血漿衍生療法不斷成長的需求。隨著血漿可及性的增加，市場上治療產品的生產不斷增加，確保了更穩健的供應鏈。此次擴張將在滿足全球對血漿衍生療法不斷成長的需求方面發揮關鍵作用，並將為市場的整體發展做出重大貢獻。

例如，2023 年，日本生物製藥公司武田製藥 (Takeda Pharmaceutical) 正在大阪建造日本最大的最先進設施，用於生產血漿衍生療法 (PDT)。這項策略性舉措增強了武田的製造和供應能力，滿足全球對 PDT 不斷成長的需求，並滿足日本及其他地區不斷成長的患者需求。此舉標誌著武田為加強血漿衍生治療市場、增強生產能力以滿足全球需求以及滿足日益成長的患者需求做出了重大貢獻。

血漿衍生治療產業根據產品、應用和地區而分散。

受白蛋白在各種醫療干預措施中的多功能應用和重要作用的推動，白蛋白細分市場將在 2032 年建立重要的市場立足點。作為一種重要的血漿蛋白，具有廣泛的治療用途，包括重症監護、手術和創傷，白蛋白將因其不可或缺的價值而脫穎而出。隨著對白蛋白療法的需求不斷成長，該細分市場將在塑造血漿衍生療法行業前景方面發揮關鍵作用。

血漿衍生療法的特發性/免疫性血小板減少性紫斑症 (ITP) 市場規模將在 2032 年大幅成長，這歸因於 ITP 發病率的不斷上升以及人們日益認知到血漿衍生療法作為有效干預措施。隨著人們越來越關注解決自體免疫疾病，特別是 ITP，對有針對性和可靠的治療方法的需求正在上升。醫學研究和治療創新的不斷進步將進一步將 ITP 領域定位為血漿衍生療法不斷擴大的領域的關鍵貢獻者，滿足關鍵的醫療保健需求。

由於其先進的醫療基礎設施和強大的研發工作，歐洲將在 2023 年和 2032 年實現顯著的CAGR。血漿相關疾病盛行率的上升加劇了這一趨勢。歐洲的醫療保健格局以技術進步和對醫療創新的承諾為標誌，凸顯了其在塑造血漿衍生治療行業發展軌跡方面的關鍵作用，使其成為該行業成長和發展的主要貢獻者。

行業細分
產業格局
產業影響力
- 成長動力
  - 罕見病患疾病率不斷上升
  - 對治療遺傳性疾病的先進療法的需求不斷成長
  - 全球血漿採集中心數量增加
  - 全國擴大採用免疫球蛋白
- 產業陷阱與挑戰
  - 嚴格的監理政策
成長潛力分析
COVID-19 影響分析
監管環境
- 美國
- 歐洲
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司矩陣分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀錶板

第 5 章：血漿衍生療法市場估計和預測：按產品分類，2018-2032 年

主要動向：按產品
免疫球蛋白
凝血因子
白蛋白
其他產品

第 6 章：血漿衍生治療市場估計與預測：按應用，2018-2032

主要動向：按應用
血友病
原發性免疫缺乏疾病
特發性/免疫性血小板減少性紫斑症 (ITP)
其他應用

第 7 章：血漿衍生治療市場估計與預測：按地區，2018 - 2032

主要動向：按地區
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 8 章：公司簡介

CSL Behring
Takeda Pharmaceutical Company Limited.
Biotest AG
Octapharma
BPL
ADMA Biologics
Grifols, SA
Kedrion
Kamada Pharmaceuticals.
SK Plasma
Pfizer, Inc.

簡介目錄圖表

Product Code: 5271

Global Plasma Derived Therapy Market will grow at a 7.5% CAGR between 2023 and 2032, owing to the expanding network of plasma collection centers and manufacturing facilities. The continuous growth of these infrastructure elements addresses the escalating demand for plasma-derived therapies. With increased accessibility to plasma, the market experiences a boost in the production of therapeutic products, ensuring a more robust supply chain. This expansion will play a pivotal role in meeting the growing global demand for plasma-derived therapies and will significantly contribute to the market's overall development.

For instance, in 2023, Takeda Pharmaceutical, a Japanese biopharmaceutical company, is constructing a state-of-the-art facility in Osaka, the largest of its kind in Japan, to manufacture plasma-derived therapies (PDTs). This strategic initiative enhances Takeda's manufacturing and supply capabilities, meeting the growing global demand for PDTs and addressing increased patient needs in Japan and beyond. This move marks Takeda's significant contribution to strengthening the plasma-derived therapy market, augmenting production capabilities to meet global demand, and addressing increasing patient needs.

The plasma derived therapy industry is fragmented based on product, application, and region.

The albumin segment will establish a significant market foothold by 2032, fueled by the versatile applications and essential role of albumin in various medical interventions. As a crucial plasma protein with widespread therapeutic uses, including in critical care, surgery, and trauma, albumin will stand out for its indispensable value. With a rising demand for albumin-based therapies, this segment will play a pivotal role in shaping the plasma derived therapy industry outlook.

The plasma derived therapy market size idiopathic/immune thrombocytopenic purpura (ITP) segment will witness substantial growth through 2032, attributed to the escalating incidence of ITP and the growing recognition of plasma-derived therapies as effective interventions. With an increasing focus on addressing autoimmune disorders, particularly ITP, the demand for targeted and reliable therapies is rising. Ongoing advancements in medical research and therapeutic innovation will further position the ITP segment as a key contributor to the expanding landscape of plasma-derived therapies, addressing critical healthcare needs.

Europe will register a notable CAGR during 2023 and 2032 due to its advanced healthcare infrastructure and robust research and development efforts. The rising prevalence of plasma-related disorders adds momentum to this trend. Europe's healthcare landscape, marked by technological advancements and a commitment to medical innovation, underscores its pivotal role in shaping the trajectory of the plasma derived therapy industry, making it a primary contributor to the industry growth and development.

Chapter 1 Methodology & Scope

1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast calculation
1.1 Covid-19 impact analysis at global level
1.2 Data validation
1.3 Data sources
- 1.3.1 Primary
- 1.3.2 Secondary
  - 1.3.2.1 Paid sources
  - 1.3.2.2 Public sources

Chapter 2 Executive Summary

2.1 Plasma derived therapy industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Product trends
- 2.1.3 Application trends
- 2.1.4 Regional trends

Chapter 3 Plasma Derived Therapy Market Insights

3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
- 3.3.1 Growth drivers
  - 3.3.1.1 Increasing prevalence of rare diseases
  - 3.3.1.2 Growing demand for advanced therapeutic for treatment of genetic disorders
  - 3.3.1.3 Increase in number of plasma collection centers across the globe
  - 3.3.1.4 Rising adoption of immunoglobulins across the nation
- 3.3.2 Industry pitfalls and challenges
  - 3.3.2.1 Stringent regulatory policies
3.4 Growth potential analysis
- 3.4.1 By product
- 3.4.2 By application
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
- 3.6.1 U.S.
- 3.6.2 Europe
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022

Chapter 5 Plasma Derived Therapy Market Estimates and Forecast, By Product, 2018-2032 (USD Million)

5.1 Key trends, by product
5.2 Immunoglobulins
5.3 Coagulation factors
5.4 Albumin
5.5 Other products

Chapter 6 Plasma Derived Therapy Market Estimates and Forecast, By Application, 2018-2032 (USD Million)

6.1 Key trends, by application
6.2 Hemophilia
6.3 Primary immunodeficiency diseases
6.4 Idiopathic/Immune thrombocytopenic purpura (ITP)
6.5 Other applications

Chapter 7 Plasma Derived Therapy Market Estimates and Forecast, By Region, 2018 - 2032 (USD Million)

7.1 Key trends, by region
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 Rest of Asia Pacific
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
7.6 Middle East & Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE
- 7.6.4 Rest of Middle East & Africa

Chapter 8 Company Profiles

8.1 CSL Behring
8.2 Takeda Pharmaceutical Company Limited.
8.3 Biotest AG
8.4 Octapharma
8.5 BPL
8.6 ADMA Biologics
8.7 Grifols, SA
8.8 Kedrion
8.9 Kamada Pharmaceuticals.
8.10 SK Plasma
8.11 Pfizer, Inc.

簡介目錄圖表

Data Tables

TABLE 1. Market revenue, by product (2022)
TABLE 2. Market revenue, by application (2022)
TABLE 3. Market share, by region (2022)
TABLE 4. Global plasma derived therapy market, 2018 - 2022 (USD Million)
TABLE 5. Global plasma derived therapy market, 2023 - 2032 (USD Million)
TABLE 6. Global plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 7. Global plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 8. Global plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 9. Global plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 10. Global plasma derived therapy market, by region, 2018 - 2022 (USD Million)
TABLE 11. Global plasma derived therapy market, by region, 2023 - 2032 (USD Million)
TABLE 12. Industry impact forces
TABLE 13. Coagulation factors market size, by region, 2018 - 2022 (USD Million)
TABLE 14. Coagulation factors market size, by region, 2023 - 2032 (USD Million)
TABLE 15. Immunoglobulins market size, by region, 2018 - 2022 (USD Million)
TABLE 16. Immunoglobulins market size, by region, 2023 - 2032 (USD Million)
TABLE 17. Albumin market size, by region, 2018 - 2022 (USD Million)
TABLE 18. Albumin market size, by region, 2023 - 2032 (USD Million)
TABLE 19. Other products market size, by region, 2018 - 2022 (USD Million)
TABLE 20. Other products market size, by region, 2023 - 2032 (USD Million)
TABLE 21. Primary immunodeficiency diseases market size, by region, 2018 - 2022 (USD Million)
TABLE 22. Primary immunodeficiency diseases market size, by region, 2023 - 2032 (USD Million)
TABLE 23. Hemophilia market size, by region, 2018 - 2022 (USD Million)
TABLE 24. Hemophilia market size, by region, 2023 - 2032 (USD Million)
TABLE 25. Idiopathic thrombocytopenic purpura (ITP) market size, by region, 2018 - 2022 (USD Million)
TABLE 26. Idiopathic thrombocytopenic purpura (ITP) market size, by region, 2023 - 2032 (USD Million)
TABLE 27. Other applications market size, by region, 2018 - 2022 (USD Million)
TABLE 28. Other applications market size, by region, 2023 - 2032 (USD Million)
TABLE 29. North America market, by country, 2018 - 2022(USD Million)
TABLE 30. North America market, by country, 2023 - 2032 (USD Million)
TABLE 31. North America plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 32. North America plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 33. North America plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 34. North America plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 35. U.S. plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 36. U.S. plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 37. U.S. plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 38. U.S. plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 39. Canada plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 40. Canada plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 41. Canada plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 42. Canada plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 43. Europe market, by country, 2018 - 2022(USD Million)
TABLE 44. Europe market, by country, 2023 - 2032 (USD Million)
TABLE 45. Europe plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 46. Europe plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 47. Europe plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 48. Europe plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 49. Germany plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 50. Germany plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 51. Germany plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 52. Germany plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 53. UK plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 54. UK plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 55. UK plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 56. UK plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 57. France plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 58. France plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 59. France plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 60. France plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 61. Italy plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 62. Italy plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 63. Italy plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 64. Italy plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 65. Spain plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 66. Spain plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 67. Spain plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 68. Spain plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 69. Rest of Europe plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 70. Rest of Europe plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 71. Rest of Europe plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 72. Rest of Europe plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 73. Asia Pacific market size, by country, 2018 - 2022(USD Million)
TABLE 74. Asia Pacific market size, by country, 2023 - 2032 (USD Million)
TABLE 75. Asia Pacific plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 76. Asia Pacific plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 77. Asia Pacific plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 78. Asia Pacific plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 79. Japan plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 80. Japan plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 81. Japan plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 82. Japan plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 83. China plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 84. China plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 85. China plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 86. China plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 87. India plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 88. India plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 89. India plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 90. India plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 91. Australia plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 92. Australia plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 93. Australia plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 94. Australia plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 95. Rest of Asia Pacific plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 96. Rest of Asia Pacific plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 97. Rest of Asia Pacific plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 98. Rest of Asia Pacific plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 99. Latin America market size, by country, 2018 - 2022(USD Million)
TABLE 100. Latin America market size, by country, 2023 - 2032 (USD Million)
TABLE 101. Latin America plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 102. Latin America plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 103. Latin America plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 104. Latin America plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 105. Brazil plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 106. Brazil plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 107. Brazil plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 108. Brazil plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 109. Mexico plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 110. Mexico plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 111. Mexico plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 112. Mexico plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 113. Argentina plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 114. Argentina plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 115. Argentina plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 116. Argentina plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 117. Rest of Latin America plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 118. Rest of Latin America plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 119. Rest of Latin America plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 120. Rest of Latin America plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 121. Middle East & Africa market size, by country, 2018 - 2022(USD Million)
TABLE 122. Middle East & Africa market size, by country, 2023 - 2032 (USD Million)
TABLE 123. Middle East & Africa plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 124. Middle East & Africa plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 125. Middle East & Africa plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 126. Middle East & Africa plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 127. South Africa plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 128. South Africa plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 129. South Africa plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 130. South Africa plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 131. Saudi Arabia plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 132. Saudi Arabia plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 133. Saudi Arabia plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 134. Saudi Arabia plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 135. UAE plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 136. UAE plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 137. UAE plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 138. UAE plasma derived therapy market, by application, 2023 - 2032 (USD Million)
TABLE 139. Rest of Middle East & Africa plasma derived therapy market, by product, 2018 - 2022(USD Million)
TABLE 140. Rest of Middle East & Africa plasma derived therapy market, by product, 2023 - 2032 (USD Million)
TABLE 141. Rest of Middle East & Africa plasma derived therapy market, by application, 2018 - 2022(USD Million)
TABLE 142. Rest of Middle East & Africa plasma derived therapy market, by application, 2023 - 2032 (USD Million)